NOV 16, 2020 11:50 AM PST

Australian COVID-19 vaccine is promising and could be released next year

WRITTEN BY: Heba El Wassef

Pharmaceutical companies worldwide are racing to develop a COVID-19 vaccine that will hopefully end this pandemic and help life return to normal. With Pfizer announcing recently that its vaccine is proving to be 90% effective against COVID-19, another vaccine candidate is also showing promising results.

Australian vaccine "UQ-CSL V451" that is being developed by a research team at the University of Queensland and biotechnology company CSL Ltd is showing to be safe with the successful production of antibodies against COVID-19 through its phase one clinical trial and is also effective in old people who are more compromised to the virus.

"The initial data is very clear, that the [UQ] vaccine is proving to be safe through phase-one clinical trials and it's proving to produce a positive antibody response,"  Federal Australian Health Minister Greg Hunt says.

"That means it's doing its job. That's particularly so in the elderly, and that is an especially important outcome, given the vulnerability to the elderly around the world from COVID-19.

 

The first phase of the UQ vaccine clinical trial begun last July and involved about 120 volunteers aging from 18-55 years old, with some of the volunteers receiving placebo. It uses a technology called the molecular clamp.

Viruses have a type of proteins called spike proteins on their envelope that helps with the attachment to the host cells membrane; these proteins induce an immune response; therefore, they are an essential target for vaccines. They tend to change their initial native viral form when expressed independently as a part of a vaccine, which leads to an ineffective immune response. The molecular clamp technology helps to overcome this problem by maintaining those proteins' shape to induce a more efficient immune response. 

CSL Ltd company is manufacturing the vaccine and working towards getting approval to start phase-three clinical trials by the end of the year, hoping to make the vaccine available by the third quarter of 2021. CSL also is manufacturing the Oxford-AstraZeneca vaccine in Victoria, Australia. 

By having more than one vaccine candidate around the world that is showing promising results in fighting COVID-19 infection, it gives us some hope that we might be getting closer to the end of this pandemic. 

Sources: 9NEWS, REUTERS, The University Of Queensland

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
SEP 27, 2021
Cell & Molecular Biology
Newly Identified Cell Type is Linked to Chronic Skin Disorders
SEP 27, 2021
Newly Identified Cell Type is Linked to Chronic Skin Disorders
The chronic skin disease atopic dermatitis (AD) is estimated to affect about 15 percent of children worldwide, and for s ...
OCT 19, 2021
Immunology
Mild COVID Produces Better Than Expected Antibody Responses
OCT 19, 2021
Mild COVID Produces Better Than Expected Antibody Responses
Over millions of years, the immune system has evolved to shield us against disease-causing pathogens that we encounter e ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
NOV 04, 2021
Immunology
The Coronavirus Infects Inner Ear Cells
NOV 04, 2021
The Coronavirus Infects Inner Ear Cells
An increasing number of COVID-19 patients have reported ear-related issues: ringing in the ear, hearing loss, and balanc ...
NOV 04, 2021
Immunology
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
NOV 04, 2021
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
One causes red, scaly patches on the skin, and the other triggers breathing difficulties, but there are some common thre ...
NOV 21, 2021
Microbiology
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
NOV 21, 2021
Rare Genetic Variant Can Make People Susceptible to Bird Flu H7N9
Zoonosis is a serious health concern, as the COVID-19 pandemic has shown. Viruses that infect one species can acquire ge ...
Loading Comments...